Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM for Breast cancer female: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 635 adverse event reports in the FDA FAERS database where PEGFILGRASTIM was used for Breast cancer female.

Most Reported Side Effects for PEGFILGRASTIM

Side Effect Reports % Deaths Hosp.
Device adhesion issue 11,326 14.0% 9 12
Wrong technique in product usage process 10,217 12.6% 13 80
Unintentional medical device removal 8,882 11.0% 7 23
Device malfunction 6,818 8.4% 3 53
Device use error 6,001 7.4% 4 20
Device issue 5,071 6.3% 7 48
Accidental exposure to product 4,967 6.1% 1 13
Device occlusion 3,239 4.0% 3 13
Off label use 3,228 4.0% 140 299
Bone pain 2,266 2.8% 48 421
Febrile neutropenia 2,154 2.7% 237 1,203
Drug dose omission 2,089 2.6% 3 52
Drug dose omission by device 2,051 2.5% 3 26
Neutropenia 1,863 2.3% 163 659
Intercepted product preparation error 1,514 1.9% 1 1

Other Indications for PEGFILGRASTIM

Product used for unknown indication (43,274) Neutropenia (21,342) Prophylaxis (7,424) Breast cancer (813) B-cell lymphoma (774) Colony stimulating factor therapy (692) Febrile neutropenia (492) Colony stimulating factor prophylaxis (436) Agranulocytosis (272) Off label use (248)

Other Drugs Used for Breast cancer female

PALBOCICLIB (17,915) DOCETAXEL (12,384) ABEMACICLIB (3,576) CAPECITABINE (2,576) CYCLOPHOSPHAMIDE (2,547) TUCATINIB (1,890) FULVESTRANT (1,292) EPIRUBICIN (1,236) TRASTUZUMAB (1,068) PACLITAXEL (887)

Related Pages

PEGFILGRASTIM Full Profile All Breast cancer female Drugs PEGFILGRASTIM Demographics PEGFILGRASTIM Timeline